ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".

Jingjing Qian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.